mCRPC – metastatic castration-resistant prostate cancer
This Medudy Master Class Series is a video tutorial for physicians on prostate cancer. This four-part module focuses on metastatic castration-resistant prostate cancer (mCRPC) and is presented by Prof. Dr. Martin Bögemann, senior physician in urology and pediatric urology at the University Hospital in Münster. The first part deals with first-line therapy for mCRPC, taking into account the […]
Darolutamide + ADT for Metastatic Hormone-Sensitive Prostate Cancer: ARASEC
This Medudy course is a video tutorial for physicians on the topic of “Darolutamide + ADT for Metastatic Hormone-Sensitive Prostate Cancer (ARASEC).” The format used here is a “Journal Club Summary,” in which we summarize the latest and most clinically relevant studies for you. In metastatic hormone-sensitive prostate cancer (mHSPC), the combination of an androgen receptor pathway inhibitor (ARPI) […]